Global Cellulite Treatment Market Report 2023: Sector is Expected to Reach $4.44 Billion by 2031 at a CAGR of 10.86% - ResearchAndMarkets.com
Global Cellulite Treatment Market Report 2023: Sector is Expected to Reach $4.44 Billion by 2031 at a CAGR of 10.86% - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Cellulite Treatment Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.
The global cellulite treatment market size attained a value of nearly USD 1.75 billion in 2022. The market is anticipated to grow at a CAGR of 10.86% during the forecast period of 2023-2031 to reach a value of USD 4.44 billion by 2031. The growth of the market can be attributed to the high demand for cosmetic procedures and the presence of advanced healthcare infrastructure.
Cellulite is a term used to describe the dimpled, lumpy appearance of the skin, especially on the thighs, hips, buttocks, and abdomen. It is caused by the accumulation of subcutaneous fat beneath the skin, which pushes against connective tissue, causing the skin to pucker and dimple. Cellulite is more common in women than men, and it is not considered a medical condition. It is generally considered a cosmetic concern, and there are various treatments available to reduce its appearance.
The cellulite treatment market refers to the range of products and services available to reduce or eliminate the appearance of cellulite on the skin. As cellulite is a common cosmetic concern, the market for cellulite treatment has grown significantly in recent years, with a wide range of options available to consumers.
These treatments can range from topical creams and lotions to invasive procedures such as liposuction. Other treatments include non-invasive procedures such as laser therapy, radiofrequency treatments, and acoustic wave therapy. These treatments aim to reduce the appearance of cellulite by either breaking down the underlying fat or smoothing out the skin's surface.
The market for cellulite treatment is driven by the increasing demand for cosmetic procedures and the growing awareness of body image issues. The availability of a wide range of treatment options and advancements in technology has also contributed to the growth of the market.
However, the effectiveness of these treatments varies, and some may be expensive or have potential side effects. Therefore, it is essential to consult a medical professional before considering any cellulite treatment.
Cellulie - Epidemiology
Cellulite is a very common cosmetic concern, particularly among women. However, as it is not a medical condition, there is no formal epidemiological data available on its prevalence or incidence. According to some estimates, it is believed that over 85% of women over the age of 21 have some degree of cellulite on their bodies. The condition is less common in men, affecting only about 10% of the male population.
Cellulite is more prevalent in older individuals, as the skin loses elasticity, and the subcutaneous fat accumulates with age. It is also more common in those who are overweight or obese. However, it can affect individuals of any weight, and even those who lead healthy lifestyles. Cellulite is more likely to appear on specific areas of the body, including the thighs, hips, buttocks, and abdomen. It can also develop on the arms and calves, although this is less common.
While cellulite is not a medical condition, its prevalence and impact on body image have led to a significant market for cellulite treatments, including topical creams, non-invasive procedures, and surgical interventions.
Key Players
The report gives an in-depth analysis of the key players involved in the cellulite treatment market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
- Cutera
- Nestle
- Merz Pharmaceuticals, LLC
- Inceler Medikal Co Ltd
- Shanghai Fosun Pharmaceutical Group Co. Ltd
- Hologic Inc
- Candela Corporation
- Mentor Worldwide LLC
- Zimmer Aesthetics
- Tanceuticals
- Nubway Co. Ltd
- Allergan
Market Segmentation
by Treatment Type
- Energy-Based Treatment
- Mechanical Suction and Thermal
- Radiofrequency
- Ultrasound
- Cry lipolysis
- Mechanical Suction
- Others
- Non-Energy Based Treatment
by Procedure Type
- Non-invasive
- Minimally invasive
- Topical
by Cellulite Type
- Soft Cellulite
- Hard Cellulite
- Oedematous Cellulite
by End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centres
- Others
by Region
North America
- United States of America
- Canada
Europe
- United Kingdom
- Germany
- France
- Italy
- Others
Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
Latin America
- Brazil
- Argentina
- Mexico
- Others
Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
For more information about this report visit https://www.researchandmarkets.com/r/9u8vd5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
